XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.22.2

Equity Incentive Plan | 6 Months Ended
--- | ---
Jun. 30, 2022
Equity Incentive Plan |
Equity Incentive Plan | Note 11 – Equity Incentive Plan In May 2020, the Company’s stockholders approved the Agree Realty Corporation 2020 Omnibus Incentive Plan (the “2020 Plan”), which replaced the Agree Realty Corporation 2014 Omnibus Equity Incentive Plan (the “2014 Plan”). The 2020 Plan provides for the award to employees, directors and consultants of the Company of options, restricted stock, restricted stock units, stock appreciation rights, performance awards (which may take the form of performance units or performance shares) and other awards to acquire up to an aggregate of 700,000 shares of the Company’s common stock. All subsequent awards of equity or equity rights will be granted under the 2020 Plan, and no further awards will be made under the 2014 Plan. As of June 30, 2022, 327,092 shares of common stock were available for issuance under the 2020 Plan. Restricted Stock - Employees Restricted shares have been granted to certain employees. The holder of a restricted share award is generally entitled at all times on and after the date of issuance of the restricted shares to exercise the rights of a stockholder of the Company, including the right to vote the shares and the right to receive dividends on the shares. The restricted shares vest over a five-year period based on continued service to the Company. The Company estimates the fair value of restricted share grants at the date of grant and amortizes those amounts into expense on a straight-line basis or amount vested, if greater, over the appropriate vesting period. The Company recognized expense relating to restricted share grants of $1.1 million and $1.0 million for the three months ended June 30, 2022 and 2021, respectively, and $2.1 million and $1.8 million for the six months ended June 30, 2022 and 2021, respectively. As of June 30, 2022, there was $11.4 million of total unrecognized compensation costs related to the outstanding restricted shares, which is expected to be recognized over a weighted average period of 3.7 years. The Company used 0% for the forfeiture rate for determining the fair value of restricted stock. The intrinsic value of restricted shares redeemed during each of the six months ended June 30, 2022 and 2021 was $1.8 million. Restricted share activity is summarized as follows: ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | Shares |  | Weighted Average
​ | ​ | Outstanding | ​ | Grant Date
​ | ​ | (in thousands) | ​ | Fair Value
Unvested restricted stock at December 31, 2021 |  | 175 | ​ | $ | 64.90
​ | ​ | ​ | ​ | ​ | ​
Restricted stock granted |  | 78 | ​ | $ | 62.72
Restricted stock vested | ​ | (56) | ​ | $ | 60.92
​ | ​ | ​ | ​ | ​ | ​
Unvested restricted stock at June 30, 2022 |  | 197 | ​ | $ | 65.15
​ Performance Units and Shares Performance units were granted to certain executive officers beginning in 2019, while performance shares were granted prior to 2019. Performance units or shares are subject to a three-year performance period, at the conclusion of which shares awarded are to be determined by the Company’s total shareholder return compared to the constituents of the MSCI US REIT Index and a defined peer group. 50% of the award is based upon the total shareholder return percentile rank versus the constituents in the MSCI US REIT index for the three-year performance period; and 50% of the award is based upon TSR percentile rank versus a specified net lease peer group for the three-year performance period. Vesting of the performance units and shares following their issuance will occur ratably over a three-year period, with the initial vesting occurring immediately following the conclusion of the performance period such that all units and shares vest within five years of the original award date. The grant date fair value of these awards is determined using a Monte Carlo simulation pricing model and compensation expense is amortized on an attribution method over a five-year period. Compensation expense related to performance units or shares is determined at the grant date and is not adjusted throughout the measurement or vesting periods. The Monte Carlo simulation pricing model for issued grants utilizes the following assumptions: (i) expected term (equal to the remaining performance measurement period at the grant date), (ii) volatility (based on historical volatility), and (iii) risk-free rate (interpolated based on 2- and 3-year rates). The Company used 0% for the forfeiture rate for determining the fair value of performance units and shares. The following assumptions were used when determining the grant date fair value: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | 2022 | ​ | 2021 | ​ | 2020
Expected term (years) | ​ | ​ | 2.9 | ​ | ​ | 2.9 | ​ | ​ | 2.9 | ​
Volatility | ​ | ​ | 33.5 | % | ​ | 33.9 | % | ​ | 18.4 | %
Risk-free rate | ​ | ​ | 1.8 | % | ​ | 0.2 | % | ​ | 1.3 | %
​ The Company recognized expense related to performance units and shares for which the three-year performance period has not yet been completed of $0.4 million for each the three months ended June 30, 2022 and 2021, and $0.7 million for each of the six months ended June 30, 2022 and 2021. As of June 30, 2022, there was $4.2 million of total unrecognized compensation costs related to performance units and shares for which the three-year performance period has not yet been completed, which is expected to be recognized over a weighted average period of 3.7 years. The Company recognized expense related to performance units and shares for which the three-year performance period was completed of $0.1 million for each of the three months ended June 30, 2022 and 2021, and $0.2 million for each of the six months ended June 30, 2022 and 2021. As of June 30, 2022, there was $0.4 million of total unrecognized compensation costs related to performance units and shares for which the three-year performance period has been completed, which is expected to be recognized over a weighted average period of 1.2 years. Performance unit and shares activity is summarized as follows:
​ | ​ | ​ | ​ | ​ | ​
​ |  | Target Number |  | Weighted Average
​ | ​ | of Awards | ​ | Grant Date
​ | ​ | (in thousands) | ​ | Fair Value
Performance units and shares at December 31, 2021 - three-year performance period to be completed | ​ | 78 | ​ | $ | 63.35
​ | ​ | ​ | ​ | ​ | ​
Performance units granted | ​ | 34 | ​ | $ | 68.59
Performance units and shares at June 30, 2022- three-year performance period completed | ​ | (27) | ​ | $ | 65.66
​ | ​ | ​ | ​ | ​ | ​
Performance units and shares at June 30, 2022 - three-year performance period to be completed | ​ | 85 | ​ | $ | 67.64
​ |  | ​ | ​ | ​ | ​
​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Shares |  | Weighted Average
​ | ​ | Outstanding | ​ | Grant Date
​ | ​ | (in thousands) | ​ | Fair Value
Performance shares - three-year performance period completed but not yet vested at December 31, 2021 |  | 27 | ​ | $ | 55.29
​ | ​ | ​ | ​ | ​ | ​
Shares earned at completion of three-year performance period (1) |  | 28 | ​ | $ | 65.66
Shares vested | ​ | (23) | ​ | $ | 54.83
​ | ​ | ​ | ​ | ​ | ​
Performance shares - three-year performance period completed but not yet vested June 30, 2022 | ​ | 32 | ​ | $ | 57.90
​ | ​ | ​ | ​ | ​ | ​
(1)Performance shares granted in 2019 for which the three-year performance period was completed in 2022 paid out at the 106% performance level
​ Restricted Stock - Directors During the six months ended June 30, 2022, 10,636 restricted shares were granted to independent members of the Company’s board of directors at a weighted average grant date fair value of $62.62 per share. The holder of a restricted share award is generally entitled at all times on and after the date of issuance of the restricted shares to exercise the rights of a stockholder of the Company, including the right to vote the shares and the right to receive dividends on the shares. The restricted shares vest over the 2022 calendar year commensurate with the board members’ annual services to the Company. The Company estimates the fair value of board members’ restricted share grants at the date of grant and amortizes those amounts into expense on a straight-line basis over the one-year vesting period. The Company recognized expense relating to restricted share grants to the board members of $0.2 million for the three months ended June 30, 2022, and $0.3 million for the six months ended June 30, 2022. As of June 30, 2022, there was $0.3 million of total unrecognized compensation costs related to the board members’ outstanding restricted shares, which is expected to be recognized over the remainder of 2022. The Company used 0% for the forfeiture rate for determining the fair value of this restricted stock.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (l) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration